BamSEC and AlphaSense Join Forces
Learn More

Savara Inc.

NASDAQ: SVRA    
Share price (12/24/24): $3.20    
Market cap (12/24/24): $549 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 45 pages 26,246,720 Shares of Common Stock Savara Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages 21,000,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 5,666,667 Shares of Common Stock Savara Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3 44 pages Savara Inc. Shares of Common Stock (Par Value $0.001 Per Share) Sales Agreement
12/34/56
EX-1.1
from 8-K 45 pages 45,785,828 Shares of Common Stock and Pre-Funded Warrants to Purchase 32,175,172 Shares of Common Stock Savara Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 45 pages 4,250,000 Shares Savara Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 46 pages 5,250,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 775,000 Shares of Common Stock Savara Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages 8,421,053 Shares Savara Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 28 pages 29,090,910 Units, Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock, of Mast Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 30,941,102 Shares of Common Stock Warrants to Purchase 22,011,265 Shares of Common Stock and Pre-Funded Warrants to Purchase 13,081,428 Shares of Common Stock Mast Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages 50,000,000 Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase 0.5 of a Share of Common Stock Mast Therapeutics, Inc. Purchase Agreement
12/34/56
EX-1.1
from S-1/A 41 pages [ — ] Units Each Unit Consisting of One Share of Common Stock and a Warrant to Purchase [ — ] of a Share of Common Stock Mast Therapeutics, Inc. Purchase Agreement
12/34/56
EX-1.1
from S-1/A 41 pages [ — ] Shares Mast Therapeutics, Inc. Common Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 40 pages 21,250,000 Shares of Common Stock and 10,625,000 Warrants of Adventrx Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13D ~20 pages Underwriting agreement
12/34/56